The U.S. on Wednesday authorized updated COVID-19 boosters for children ... booster was cleared only for adults. FDA just expanded that adult bivalent dosage to 12- to 17-year-olds, and authorized ...
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...
A medical staff member prepares a vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at ... Some 48,400 shots have already been delivered to adults in residential care homes ...
On January 20, two days ahead of Lunar New Year, a total of 4,589 Covid-19 shots were administered, including 3,819 of the bivalent vaccine. The daily seven-day average for all types of vaccines ...
COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.
SHANGHAI — China's vaccine developers stuck with unused mRNA Covid shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough ...
The days of free COVID-19 vaccine shots in Japan may be numbered. The Finance Ministry on Nov. 7 asked an advisory panel to start discussing possible charges for the COVID-19 shots, like the ones ...
“Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease,” the FDA pointed out. “The most commonly reported side effects by those clinical ...
Argentina's Health Ministry Carla Vizzotti insisted that people needed to get an additional shot of Covid-19 vaccine if ... and announced the country would have bivalent vaccines available in ...
“On a weekly basis, I miss Switzerland. In a smaller place, it did feel very safe — the kids were able to walk to and from school,” admits Peck. “But I feel happy that our children have a ...
However, ministry sources have said they are considering policy changes to dispense COVID-19 vaccinations as they would for flu shots or vaccines for other seasonal illnesses. That means ...
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.